Currently no treatment is available but there is an ongoing small open-label pilot study looking at using recombinant human prolactin
Sheehan's syndrome
Addison's disease
Cushing's syndrome
Wolff–Parkinson–White syndrome
Wellens' syndrome
Ménière's disease
Paget-Schroetter syndrome
Congenital adrenal hyperplasia